158 related articles for article (PubMed ID: 30344909)
1. Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.
Tjin CC; Wissner RF; Jamali H; Schepartz A; Ellman JA
ACS Med Chem Lett; 2018 Oct; 9(10):1013-1018. PubMed ID: 30344909
[TBL] [Abstract][Full Text] [Related]
2. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
3. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
4. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
[TBL] [Abstract][Full Text] [Related]
7. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
9. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
11. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.
Luo Y; Knuckley B; Bhatia M; Pellechia PJ; Thompson PR
J Am Chem Soc; 2006 Nov; 128(45):14468-9. PubMed ID: 17090024
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
[TBL] [Abstract][Full Text] [Related]
13. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.
Rechiche O; Lee TV; Lott JS
Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):334-340. PubMed ID: 34605437
[TBL] [Abstract][Full Text] [Related]
15. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
[TBL] [Abstract][Full Text] [Related]
16. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
[TBL] [Abstract][Full Text] [Related]
17. Facile fluorescence-based detection of PAD4-mediated citrullination.
Wildeman E; Pires MM
Chembiochem; 2013 May; 14(8):963-7. PubMed ID: 23640867
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides.
Ahmad Nadzirin I; Chor ALT; Salleh AB; Rahman MBA; Tejo BA
Comput Biol Chem; 2021 Jun; 92():107487. PubMed ID: 33957477
[TBL] [Abstract][Full Text] [Related]
19. Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.
Saijo S; Nagai A; Kinjo S; Mashimo R; Akimoto M; Kizawa K; Yabe-Wada T; Shimizu N; Takahara H; Unno M
J Mol Biol; 2016 Jul; 428(15):3058-73. PubMed ID: 27393304
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.
Bawadekar M; Gendron-Fitzpatrick A; Rebernick R; Shim D; Warner TF; Nicholas AP; Lundblad LK; Thompson PR; Shelef MA
Arthritis Res Ther; 2016 Jul; 18(1):173. PubMed ID: 27450561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
